QCG
BHVN icon

Quadrant Capital Group’s Biohaven BHVN Stock Holding History

Quadrant Capital Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$153 – 1412
2026
Q1 		$153 Sell
18
-111
-86% -$1.21K ﹤0.01% 2681
2025
Q4 		$1.46K Buy
129
+111
+617% +$1.38K ﹤0.01% 2557
2025
Q3 		$271 Buy
+18
New +$262 ﹤0.01% 2643
2025
Q2 		– Sell
-41
Closed -$986 – 1496
2025
Q1 		$986 Hold
41
– – ﹤0.01% 2593
2024
Q4 		$1.53K Hold
41
– – ﹤0.01% 2534
2024
Q3 		$2.05K Sell
41
-1
-2% -$39 ﹤0.01% 2497
2024
Q2 		$1.46K Hold
42
– – ﹤0.01% 2520
2024
Q1 		$2.3K Hold
42
– – ﹤0.01% 2479
2023
Q4 		$1.8K Sell
42
-22
-34% -$684 ﹤0.01% 2492
2023
Q3 		$1.67K Buy
64
+22
+52% +$457 ﹤0.01% 2433
2023
Q2 		$1K Hold
42
– – ﹤0.01% 2499
2023
Q1 		$574 Sell
42
-17
-29% -$271 ﹤0.01% 2589
2022
Q4 		$819 Sell
59
-73
-55% -$1.03K ﹤0.01% 2573
2022
Q3 		$20K Buy
+132
New +$958 ﹤0.01% 1526

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quadrant Capital Group's BHVN Position: Q2 2026 in Review

Quadrant Capital Group sold out of Biohaven (BHVN) in Q2 2026, closing a stake of 18 shares — an estimated $153 sold.

Quadrant Capital Group first reported a position in BHVN in Q3 2022 and held it in 14 quarters. The position peaked at $20K in Q3 2022. 294 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Quadrant Capital Group reported no remaining Biohaven position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 18 Biohaven shares in Q2 2026, an estimated $153.
  • Quadrant Capital Group first reported a position in Biohaven in Q3 2022 and held it in 14 quarters.
  • Quadrant Capital Group's Biohaven position peaked at $20K in Q3 2022.
  • 294 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.